$VICR

VINCIARELLI PATRIZIO sold $320K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 1,000 shares of VICOR CORP (VICR) at $320.18 ($0.32M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 3, 2026, 3:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 3:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

This provides a fresh, timestamped datapoint on insider liquidity. However, 10b5-1 structure generally lowers the informational content versus non-plan discretionary sales.

02

Market read

Useful for monitoring insider activity and potential short-term sentiment/flow, but unlikely to change valuation absent other catalysts.

03

What to watch

Traders may overreact to insider selling; the key is whether there are repeated sales patterns or concurrent fundamental news (not present here).

Relevance 6/10Novelty 6/10Timing: New SEC Form 4 filed today (2026-06-03) covering a 2026-06-02 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor Corp, showing an open-market sale by the CEO/Chairman under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s CEO/Chairman sold $320K of VICR shares via a pre-arranged 10b5-1 open-market sale disclosed on SEC Form 4.

Expected impact

Likely limited immediate price impact; any reaction is more sentiment/flow-driven than fundamental.

Evidence & confidence

The filing provides a concrete insider transaction datapoint, but explicitly notes a pre-arranged 10b5-1 plan, reducing signal strength.

Market effects

Minimal; this is company-specific insider activity with no stated operational or sector catalyst.

None indicated; single-US-listed issuer disclosure.

None indicated beyond VICR-specific trading/positioning.

Counterpoint

Because the sale is on a pre-arranged 10b5-1 schedule, it may reflect planned liquidity rather than bearish expectations.

Key entities

  • VICOR CORP

    US-listed company whose CEO/Chairman reported an open-market sale of shares via a pre-arranged 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: